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Abstract
Background: The ten year probability of cardiovascular events can be calculated, but many people are
unaware of their risk and unclear how to reduce it. The aim of this study was to assess whether a
community based intervention, for men and women aged between 45 and 64 years without pre-existing
coronary heart disease, would reduce their Framingham scores when reassessed one year later.
Methods: Individuals in the relevant age group from a defined geographical area were sent an invitation
to attend for an assessment of their cardiovascular risk. Individuals with pre-existing cardiovascular disease
or terminal illness were excluded. The invitation was in the form of a "Many Happy Returns" card with a
number of self-screening questions including the question, "If you put the enclosed string around your
waist, is it too short?" The card contained a red 80 cm piece of string in the case of women, or a green 90
cm piece of string in the case of men. At the assessment appointment, Framingham scores were calculated
and a printout was given to each individual. Advice was provided for relevant risk factors identified using
agreed guidelines. If appropriate, onward referral was also made to a GP, dietician, an exercise referral
scheme, or to smoking cessation services, using a set of guidelines. Individuals were sent a second
invitation one year later to return for re-assessment.
Results and discussion: 2031 individuals were asked to self-assess their eligibility to participate, 596
individuals attended for assessment and 313 of these attended for follow-up one year later. The mean
reduction in the Framingham risk score, was significantly lower at one year (0.876, 95% CI 0.211 to 1.541,
p = 0.01). The mean 10-year risk of CHD at baseline was 13.14% (SD 9.18) and had fallen at follow-up to
12.34% (SD 8.71), a mean reduction of 6.7% of the initial 10-year Framingham risk. If sustained, the
estimated NNT to prevent each year of CHD would be 1141 (95% CI 4739 to 649) individual
appointments.
Conclusion: This community intervention for primary prevention of CHD reduces Framingham risk
scores at one year in those who engage with the programme.
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A range of risk factors for coronary heart disease (CHD)
have been identified and the probability of adverse cardi-
ovascular events over the subsequent 10 years can be pre-
dicted using tools such as the Framingham Risk Score [1].
The risk of cardiovascular disease can be modified by a
number of behavioural changes and by treatment of undi-
agnosed hypertension and lipid disorders. However,
many individuals are unaware of their level of risk and do
not have access to information that might influence their
health behaviour.
A case can be made for identifying 'at risk' individuals,
particularly over 45 years of age and for providing them
with advice on reducing their risk. There is good evidence
that secondary prevention interventions are effective [2,3]
but there is less evidence for interventions aimed at pri-
mary prevention of CHD. Most General Practitioners
(GPs) undertake opportunistic screening and have com-
piled CHD registers. However, many individuals are not
identified by this opportunistic screening, either because
they have not attended their GP, have not been opportun-
istically assessed when visiting their GP, or perhaps have
not been identified as 'at risk' of CHD because they avoid
contact with health service providers. Universal screening
of the whole population is not merited as the risk of CHD
rises with age and the great majority of individuals
younger than 45 years have a low risk of CHD in the sub-
sequent 10 years. This study consequently encouraged a
degree of self selection using a range of self assessment cri-
teria, although patients not meeting these criteria were not
rigidly excluded.
Consequently, the aim of this study was to assess whether
a community based intervention, for men and women
aged between 45 and 64 years without pre-existing coro-
nary heart disease, would reduce their Framingham risk
scores when reassessed one year later. A secondary aim of
this study was to assess which risk factors had changed
most over the course of the year and so contributed most
to any reduction in Framingham risk scores.
Methods
Men and women aged between 45 and 64 years and regis-
tered with three GP practices in the Rhymney Valley,
Wales were identified. The practices had 4,672 patients
registered with them in the relevant age group. This area
was chosen because it has a high level of social depriva-
tion and a high Standardised Mortality Rate for CHD.
Individuals who had pre-existing cardiovascular disease
and were on the practices' CHD registers were identified
and excluded, as were patients with known terminal dis-
ease. Each week between September 2004 and March
2005, approximately 200 individuals in the relevant age
group were sent an invitation to self-screen for eligibility
to attend for an assessment of their risk of heart disease
until all eligible patients in the GP practices had been
invited. The invitation was in the form of a "Many Happy
Returns" card containing a number or questions and
enclosing a red 80 cm piece of string in the case of women,
and enclosing a green 94 cm piece of string in the case of
men. The invitation card, which was intended to stimulate
reflection on CHD risk factors, included the following:
"Have you ever been told you have high blood pressure?
Have you ever been told you have high cholesterol? Do
you smoke now or have you smoked in the past 15 years?
Has your mother, father, brother or sister ever had heart
problems, before they were 60 years old? If you put the
enclosed string around your waist, is it too short? You
could benefit from a free health check to help prevent
heart problems if you ticked any of the 'yes' boxes". The
card invited eligible individuals to phone and make an
appointment for the assessment. A single reminder was
sent out two weeks after the first invitation. When individ-
uals telephoned the free telephone number provided, a
range of dates were offered over the subsequent four
weeks for the assessment to be undertaken.
The assessment clinics were held in community venues
not normally associated with health care. At the clinic,
individuals were provided with an information sheet,
filled in a number of questionnaires, and signed a consent
form allowing the data gathered to be used for research
purposes. Framingham scores were calculated using a
computer programme called CV-R Profile [4]. This pro-
duced a printout, which was given to each individual seen.
Advice was provided for relevant risk factors identified
using agreed guidelines. Where relevant, onward referral
was also made to the individual's GP, a dietician, an exer-
cise referral scheme, or to local smoking cessation serv-
ices, using a set of guidelines based on published sources
[5-7]. Some individuals were referred to more than one
source of subsequent advice or assessment. Satisfaction
questionnaires were completed by individuals at the end
of their assessment. Individuals that attended were sent a
second invitation one year later to return to an identical
clinic for re-assessment of their Framingham risk score.
Ethical approval for the study was obtained from the local
NHS research ethics committee.
The study was developed by a group of public health staff
in Caerphilly Local Health Board (LHB) with advice from
academic colleagues as a bid for funding to address "ine-
qualities" in Caerphilly LHB. It was piloted on staff in the
LHB and in a neighbouring cottage hospital. The experi-
ence gained was used to make changes that were incorpo-
rated into the final design.
Data was analysed using SPSS 14. The paired t-test for 'the
difference between means for paired samples' was usedPage 2 of 8
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coxon Signed-Rank Test, Mann-Whitney Test, or Chi-
square test was used elsewhere.
Results
Of the 2,031 individuals invited to assess their eligibility,
596 individuals attended for assessment and 313 of these
attended for follow-up one year later (Figure 1). Consent
was obtained and data was available for analysis on 290
individuals (148 men and 142 women) who did re-attend
for follow-up and on 281 individuals who did not re-
attend for follow-up (Table 1). Participants were almost
all of Caucasian origin, reflecting the ethnicity of the local
population. The 'Did Not Attend' (DNA) rate for those
who had made appointments was 7.4% for the initial visit
and 5.8% for the follow-up visit.
The main outcome of the study, the mean reduction in the
Framingham risk score, was slightly lower at one year
(0.876%, 95% CI 0.21% to 1.54%). The mean 10-year
risk of CHD at baseline was 13.14% (SD 9.18) and had
fallen at follow-up to 12.34% (SD 8.71), a mean reduc-
tion of 6.7% of the initial 10-year Framingham risk.
Table 2 indicates that weight, BMI and waist circumfer-
ences worsened at follow-up. However, other characteris-
tics: pulse, systolic BP, total cholesterol, HDL, and glucose
profiles significantly improved, even accounting for the
multiple statistical comparisons undertaken. Figure 2
indicates that waist circumferences correlated with Fram-
ingham risk scores in both men and women but with a
wide spread of results.
Assessment of relevant health behaviours indicated that,
at follow-up, smoking had decreased, alcohol intake had
decreased, and regular exercise had increased, although
the extent of the changes observed was not statistically sig-
nificant. The greatest behavioural change was in reported
intake of fruit and vegetables, where the increase was sta-
tistically significantly (Wilcoxon signed rank test, p >
0.001).
Groups with the greatest improvement
Three factors were significantly associated with being in
the one third of individuals who had the largest reduc-
tions in Framingham risk score at one year: higher initial
Framingham risk score, referral onwards to another serv-
ice (for further advice, assessment, treatment or health
promoting activity), and older age.
Individuals who had been referred onwards to another
service for further advice had a large fall in their mean
Framingham risk score (1.869%), whereas those who
were not referred onwards had very little fall in their Fram-
ingham risk score (0.155%). The mean difference in the
change of risk scores between those who were referred
onwards and those who were not was 1.71% (95% CI
0.38% to 3.05%, p = 0.012). As would be expected, those
referred onwards had higher initial Framingham risk
scores.
Details of the nature of the 169 onward referrals, made on
122 individuals, are shown in Table 3. One individual had
four onward referrals, four individuals had three onward
referrals, 36 individuals had two onward referrals and 81
individuals had one onward referral. Onward referral had
an effect on reducing smoking but not on exercise, alcohol
intake or fruit and vegetable intake (Table 4).
Table 5 indicates that those who were in older age groups
were significantly more likely to be in the one third of
individuals with the greatest improvement in Framing-
ham score (Chi square, p = 0.043).
A significant difference was noted in this study between
men and women in the reporting of a family history of
heart disease, although most men and women were indig-
enous to the area and therefore drawn from the same
extended family networks. A family history of CHD was
reported by 33.5% of women, but only 15.0% of men
(Chi square p < 0.001).
Evaluation forms, completed by 452 individuals after
attending their initial assessment appointment, indicated
that 98% found the appointment 'very useful', 1.3% 'use-
ful', 0.2% 'not very useful' and 0.4% did not complete the
evaluation question. The venue used was considered 'suit-
able' by 96% as against 3.8% who considered it 'unsuita-
ble'.
Comparison with those who did not re-attend
A number of differences were identified in the baseline
characteristics between those who returned for follow-up
at one year and those who did not. The mean Framing-
ham risk score for those who did not return for follow-up
(14.7%) was slightly higher than the mean risk score for
those who did return (13.2%). In addition, those who
returned for follow-up were, on average, 1.23 years older
than those who did not return for follow-up. Men were
Table 1: Study participants by age and gender
Age band Female Male Total
45–49 yrs 21 22 43
50–54 yrs 36 34 70
55–59 yrs 47 37 84
60–64 yrs 44 49 93
Total 148 142 290Page 3 of 8
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Flow diagram of study participantsigure 1
Flow diagram of study participants.
Invited from primary 
care register = 
2031(1013 female, 
1018 male) 
Booked first clinic = 
596 (322 female, 274 
male) 
(Data available on 571)
Seen at follow up clinic 
= 313 (161 female, 152 
male) 
Available data for 
analysis = 290 (148 
male, 142 female) 
Did not book clinic 
following self 
assessment = 1391 
Booked clinic but did 
not attend = 44 
Did not respond to 
follow up invitation = 
265 
Booked but did not 
attend = 18
Data incomplete = 23 
BMC Cardiovascular Disorders 2008, 8:18 http://www.biomedcentral.com/1471-2261/8/18also slightly more likely to return for follow-up than
women (52.8% cf. 49.0%).
Using the mean reduction in Framingham risk score of
0.876% over 10 years, suggests a number needed to treat
(NNT) of 114.1 to prevent one person developing heart
disease over 10 years, or 1141 (95% CI 4,739 to 649) indi-
vidual appointments to prevent each year of CHD.
Making the conservative assumption that out of the 2,031
individuals invited, improvement only occurred in the
313 who returned for re-assessment at one year, an invita-
tion would need to be sent by the programme to 7,407
individuals (95% CI 4,202 to 30,769) to prevent one year
of CHD in one notional individual. At an estimated cost
of at least £20 per individual seen, this equates to at least
£150,000 to prevent one year of CHD in one notional
individual.
Discussion
This study's main finding is that a community based pro-
gramme inviting men and women aged between 45 and
64 years, who do not have pre-existing coronary heart dis-
ease, assessing their 10-year risk and providing appropri-
ate advice or onward referral related to risk factors
identified, slightly reduced the subsequent risk of CHD, as
measured by Framingham scores one year later. The mag-
nitude of the mean reduction in the estimated 10-year risk
of developing cardiovascular disease was 0.876% against
a mean initial 10-year estimated risk of CHD of 13.14% in
this population. Based on our reading of the literature,
our aim was to reduce the average Framingham risk score
by 7%. The reduction we achieve was slightly smaller than
this (6%). However, the clinical significance of a less than
one percent absolute change in Framingham Risk Score is
not clear.
There was some evidence that the change which was
observed may have been mediated through onward refer-
ral for a number of further interventions including: fur-
ther assessment, reinforcing advice, or relevant
prescription of medication. Those at greatest risk and
those who were older at the time of assessment seem to
have benefited most. There was some evidence that the
intervention had improved self-reported behaviours
around diet, exercise, smoking and alcohol consumption.
The intervention positively impacted on diet, exercise,
alcohol intake and smoking behaviour but did not appear
to have a beneficial impact on obesity and further work is
needed to address this risk factor [8].
Blood pressure and lipid levels were also improved,
although the size of the observed fall in blood pressure
was similar to that which has been observed as a result of
regression towards the mean, or a placebo effect, dis-
played in the control groups of some clinical trials. The
adverse BMI and weight changes are not directly reflected
in the Framingham risk score and have, therefore, not
been reflected in the fall in mean risk scores. It is unclear
whether the observed increases in weight would have
adversely affected the estimated risk of CHD in such indi-
viduals.
The study is not representative of areas with lower rates of
CHD nor would it be generalisable to areas with low rates
of CHD. The GP practices from which individuals were
invited were in an area of high rates of CHD. Standardised
Table 2: Changes in risk factors from baseline to follow-up at one year for study participants
Improved Metric Mean Std. Deviation Sig. (2-tailed)
Baseline Weight (kg) 78.95 16.735
1. No Follow-up Weight (kg) 79.367 16.8307 0.023
Baseline BMI 28.13 4.843
2. No Follow-up BMI 28.38 4.872 0.001
Baseline Waist circumference (cm) 89.56 17.027
3. No Follow-up Waist circumference (cm) 90.94 13.656 0.059
Baseline Systolic BP (mmHg) 141.53 18.681
4. Yes Follow-up Systolic BP (mmHg) 138.65 17.014 <0.001
Baseline Diastolic BP (mmHg) 83.78 9.606
5. Yes Follow-up Diastolic BP (mmHg) 82.65 10.449 0.022
Baseline Pulse Pressure 57.75 13.873
6. Yes Follow-up Pulse Pressure 55.93 12.745 0.003
Baseline Total Cholesterol 5.5113 1.04420
7. Yes Follow-up Total Cholesterol 5.3530 .99085 0.002
Baseline HDL (mmol/l) 1.2777 .37721
8. Yes Follow-up HDL (mmol/l) 1.3787 .40722 <0.001
Baseline Glucose (mmol/l) 5.4884 .90338
9. Yes Follow-up Glucose (mmol/l) 5.305 1.1556 0.008Page 5 of 8
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Welsh Public Health Common Data Set for the five years
1995–99, for the wards from which these patients were
drawn were: New Tredegar (134.2), Darren Valley
(126.4), Moriah (119.2), Pontlottyn (126.0). The GP
practices used were the main providers of primary care to
the above wards and were, therefore, representative of the
patients living in this area. The study does demonstrate
the potential feasibility of reducing "inequalities" in some
CHD risk factors in communities with very high rates of
CHD.
This study was undertaken in a service setting, rather than
a purely academic context, and should therefore be rela-
tively easy to replicate. The most significant weakness in
the study has been the lack of a control group although we
hope to measure differences in the mortality rates
between participating practices in the target area and non
participating practices in an adjacent area. However, as
this information is not available at an individual patient
level, it will be open to the ecological fallacy. We do not
have comparable data on non-participants from the rele-
vant GP practices, as it was considered unethical to use the
GP surgery databases to obtain information on patients
without their consent.
A significant proportion of those invited to a follow-up
appointment one year later did not choose to re-attend,
and this group appears to have had a higher average risk
of CHD, a finding that has been replicated elsewhere [9].
Younger individuals in the cohort were also less likely to
re-attend for assessment. However, the interventions
appears to have been well received as evaluation immedi-
ately after the initial appointment indicated that over 99%
of all attendees had found the content of the assessment
'useful'.
Scatter plot of Framingham score (10-year risk of CHD) against waist circumference (cm)Figure 2
Scatter plot of Framingham score (10-year risk of CHD) against waist circumference (cm).Page 6 of 8
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algorithm was used in this study [1] may over estimate
risk [10] or underestimate the risk [11]. However, it has
been widely used in CHD research and clinical practice to
communicate risk to individuals and is easily understood
and calculated.
The confidence intervals used to assess the changes in the
mean differences in Framingham scores, in the results
provided, are also open to the criticism that they do not
take into account the underlying variance arising from the
different risk factors incorporated into each individual's
specific risk estimate. The true standard deviations and
confidence intervals for the mean Framingham risk scores
provided for different groups may, therefore, be larger
than those that have been presented.
A number of studies and systematic reviews [12-14] have
assessed multifaceted interventions to reduce the risk of
CHD and have demonstrated reductions in risk factors,
although not necessarily in mortality rates. The effective-
ness of these interventions appears to be greatest in those
at greatest risk of CHD. However, it is difficult for individ-
uals to assess their risk of CHD without information on
their lipid profile, which requires blood sampling. This
suggests that there is a need for tools that individuals
could use themselves as an initial screening measure
before further clinical assessment. This study used a set of
self-administered questions inside a card as an initial
'screening tool', which meant that those attending for the
calculation of a Framingham risk score were at increased
risk of CHD. However, there is the potential to refine the
set of self-completed questions in the initial invitation
and further differentiate those at very low risk and who are
least likely to benefit from further assessment, from those
at higher risk who would benefit from further assessment.
A piece of string was included with instructions to use it as
a 'screening tool' to assess their own abdominal circum-
ference based on previous research which indicates that
abdominal circumference predicts CHD risk [15]. Using
"waist circumference greater than the piece of string pro-
vided" as a 'screening test', to identify those individuals
with a Framingham risk of 10% or greater, would have
had a sensitivity of 75.4% in women and 76.1% in men
within the cohort who attended our clinics. Using this cri-
terion on its own, to invite individuals for further assess-
ment, would have missed a significant proportion of
those with a Framingham risk of greater than 10%.
There are a number of areas where further work could be
undertaken to improve and build on this intervention.
Individuals varied widely in the effect of the intervention.
There is a need to explore the varying experiences of indi-
viduals involved in the study, particularly those whose
scores had changed most radically to assess those aspects
of the intervention that had most influenced them. It may
also be possible to further enhance participation rates,
effectiveness and impact of advice given, for example by
using motivational interviewing. The screening questions
in the invitation card could also be modified to increase
the effectiveness of the self-assessment as a screening tool.
Conclusion
This community intervention for primary prevention of
CHD reduces Framingham risk scores at one year in those
who engage with the programme. It is unclear to what
extend this effect is sustained in the longer term although
follow up is ongoing. There may also be scope for further
refining the intervention to target those individuals that
are at highest risk of CHD but have not previously been
identified by other means.
Table 3: Type and number of onward referrals
Type of referral Referrals
Cardiac Rehabilitation 1
GP/nurse re blood pressure 52
GP/nurse re cholesterol 83
GP/nurse re other concerns 17
GP/nurse re exercise 0
Dietician re weight 7
Smoking Cessation 4
Exercise Referral via a "Health Living" Centre 3
Dietician Referral re cholesterol 2
Total 169
Table 4: The effect of onward referral on changes in behaviours to reduce CHS risk at one year follow-up
Not Referred onwards Referred onwards to any service provider Chi-square p value
Risk factor reduced Risk factor increased Risk factor reduced Risk factor increased
Smoking 11 15 19 8 0.04
Exercise 62 45 37 36 0.33
Alcohol 37 36 22 21 0.96
Fruit and veg intake 63 30 40 25 0.42
*Cases where there has been no change in behaviour have been excludedPage 7 of 8
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Table 5: Change in Framingham score by age group when reviewed after one year
Change in Framingham scores (%) 45–49 yrs 50–54 yrs 55–59 yrs 60–64 yrs Total
Third with greatest improvement % 15 20 40 46 121
34.9% 28.6% 47.6% 49.5% 41.7%
Middle third % 10 28 22 21 81
23.3% 40.0% 26.2% 22.6% 27.9%
Third with least improvement % 18 22 22 26 88
41.9% 31.4% 26.2% 28.0% 30.3%
Total (individuals in age band) % 43 70 84 93 290
100.0% 100.0% 100.0% 100.0% 100.0%
Chi square, p = 0.043. Thirds are not identical in size as the data is ordinal and can therefore only be approximately split into three groups.Page 8 of 8
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